Sep 13, 2022 / 01:05PM GMT
Eric White Coldwell - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Okay. Great. Good morning, everyone. My name is Eric Coldwell. I cover pharma services at Baird, and it's our pleasure to introduce Labcorp today. We have Glenn Eisenberg, EVP and CFO of the company. And we're going to dispense with the formalities and jump straight into Q&A, I think, just do a nice fireside chat. Feel free to come in as you need to.
Glenn, I'm going to let you just do that very quick intro and give us an update, and then we'll jump right into the Q&A.
Glenn A. Eisenberg - Laboratory Corporation of America Holdings - CFO & Executive VP
Great. No, that's great. Well, first of all, great being here with everybody. Adam Schechter, Labcorp's CEO, sends his apologies. He had a conflict that he wasn't able to be able to join us today but look forward to being with you all.
And as Eric said, a lot of exciting things going on with the company these days across the breadth of our businesses and really look forward to
Laboratory Corporation of America Holdings at Robert W Baird Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot